Military University Hospital Prague
Prague, 16209, Czechia
Location status: Recruiting
NCT Number: NCT07249983
A prospective, two-phase interventional study evaluating the performance, safety, and usability of the SaCoVLM™ video laryngeal mask airway for airway management by military medics with limited intubation experience. The study includes simulation-based training and clinical application in sedated patients undergoing elective surgery.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Prague, 16209, Czechia
Location status: Recruiting
This prospective, two-phase study evaluates the use of the SaCoVLM™ video laryngeal mask airway by military medics with limited airway experience. Phase 1 involves simulated intubation on manikins to assess device placement, visualization quality, and intubation success. Phase 2 evaluates clinical performance in adult patients undergoing elective surgery under general anesthesia. Key outcomes include first-attempt success rates, insertion and intubation times, glottic visualization scores, and complication rates. The study aims to determine whether SaCoVLM™ can enable safe and effective airway management in resource-limited and prehospital military settings.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Simulation-based and clinical use of SaCoVLM™ for airway management and intubation.
Time frame: Within 10 minutes of airway intervention.
Proportion of cases in which the SaCoVLM™ is successfully inserted on the first attempt during both simulated and clinical phases.
Time frame: Within 10 minutes following SaCoVLM™ placement.
Proportion of successful orotracheal intubations on the first attempt using the SaCoVLM™ device as a conduit.
Time frame: During initial airway management (simulation or clinical setting).
Time in seconds from picking up the device to successful confirmation of placement.
Time frame: During initial airway management (simulation or clinical setting).
Time in seconds from introduction of the endotracheal tube into the SaCoVLM™ to confirmed tracheal placement.
Time frame: Immediately after SaCoVLM™ placement.
Laryngeal view quality assessed using Keller-Brimacombe scale. The Keller-Brimacombe score ranges from Grade 1 (vocal cords not visible) to Grade 4 (only vocal cords visible with a full, unobstructed view), with higher grades indicating better glottic visualization and alignment for intubation.
Time frame: Immediately after each procedure.
Operator-rated difficulty of device use on a 10-point visual analog scale (VAS).
Time frame: From initiation of airway management to induction of general anesthesia (clinical phase only).
Number of adverse airway events including hypoxemia (SpO₂ < 90%), laryngospasm, or aspiration.
Contact information is provided by the study sponsor or research team.
Jan Palenik, M.D.
CONTACT
Ladislav Šindelář, M.D.
CONTACT
Charles University, Czech Republic
Other
Evaluation of SaCoVLM™ Video Laryngeal Mask Airway for Airway Management by Inexperienced Military Medics: A Two-Phase Feasibility Study
Acronym: SAVER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06953414
Airway Management, Anesthesia
Hamburg, Free and Hanseatic City of Hamburg, Germany
View Trial DetailsNCT07699653
Airway Management, General Anesthesia
Guangzhou, Guangdong, China
View Trial DetailsNCT07574450
Airway Management, Cardiovascular Diseases
New Taipei City, Taiwan
View Trial DetailsNCT06689748
Airway Management, Critical Illness
Dallas, Texas, United States
View Trial Details